Drug LitigationInside Story Behind Johnson & Johnson’s Risperdal 20 Year Cover Up

Huffington Post has published “The Miracle Industry Series,” where the news outlet reveals that Johnson & Johnson spent 20 years marketing the drug Risperdal to children and the elderly. Once again, pharmaceutical profits won out over safety and the truth about the side effects. Huffington Post reveals that Johnson & Johnson’s “strategies, tactics, and mindset should make us wonder about the prescription drugs that are so much a part of our lives.” Chapter 15 of the series is due to be released on September 29, 2015. Chapter 1 starts here: http://highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/chapter-1.html

The antipsychotic drug Risperdal has been linked to breast development in young boys. Psychopharmacology published first study results in January 1999, associating Risperdal with gynecomastia. The study reported Risperdal caused gynecomastia when used in conjunction with the antidepressant Prozac, which contains fluoxetine. Patients who have developed Risperdal gynecomastia are encouraged to speak with an experienced pharmaceutical injury attorney immediately. Risperdal has been proven to cause breast development in young boys, or pituitary cancer and tumors. Other symptoms of Risperdal caused gynecomastia include pain, tenderness, or swelling of the breasts, and/or nipple discharge. Gynecomastia can be emotionally and psychologically damaging, and may require surgical correction. If you or a loved one have taken Risperdal to treat bipolar disorder, schizophrenia, or behavioral issues associated with autism, you may be entitled to cash compensation. Contact our team of attorneys today by email or phone at +1.888.545.7402 for a free evaluation of your case today.